SCHEMBL26010079

SCHEMBL26010079

C[C@@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O)N(C)C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.51
ITGB3 P05106 1/20 0.51
ITGA2B P08514 1/20 0.51
LTA4H P09960 1/20 0.45
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
CTSL P07711 3/20 0.41
CTSB P07858 3/20 0.41
CTSS P25774 3/20 0.41
CTSK P43235 3/20 0.41
CTRB1 P17538 2/20 0.41
MAPT P10636 2/20 0.41
FOLH1 Q04609 1/20 0.41
P2RX7 Q99572 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30688544 0.90 ITGB3 (0.58) ABCB1ITGB3ITGA2BLTA4HMMP2
SCHEMBL30688553 0.90 ITGB3 (0.58) ABCB1ITGB3ITGA2BLTA4HMMP2
SCHEMBL30688507 0.90 ITGB3 (0.58) ABCB1ITGB3ITGA2BLTA4HMMP2
SCHEMBL8067076 0.89 ITGB3 (0.59) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL2968658 0.89 ITGB3 (0.59) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL31739224 0.89 ITGB3 (0.59) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL2494968 0.89 ITGB3 (0.59) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL26654521 0.88 ITGB3 (0.58) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL26654515 0.88 ITGB3 (0.58) ABCB1ITGB3ITGA2BALDH1A1HPGD
SCHEMBL23893394 0.87 LTA4H (0.52) ABCB1LTA4HALDH1A1HPGDCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303619-A1 DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-09-28 US disclosed
US-11732002-B2 Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11732002-B2 Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound VIP, PEPD, MLN ABCB1 4263/4885ITGB3 3392/4885ITGA2B 3226/4885
US-20230303619-A1 DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND VIP, PEPD, MLN ABCB1 4263/4885ITGB3 3392/4885ITGA2B 3226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.